...to be completed by Jan. 2013. Companies in Endeavour's New Zealand portfolio include proteomics biotech Protemix Corp. Ltd....

...containing thiazide, atenolol, ramipril, simvastatin and aspirin Reduce risk factors for cardiovascular disease Ph II Protemix Corp. Ltd....

...Rating (HAM-D) score in a Phase IIb trial for major depressive disorder (MDD). PX811019 from Protemix Corp. Ltd....
...to treat non-diabetic heart failure, as well. COO and CFO David Pool told BioCentury that Protemix...
...Inc. (NASDAQ:OSIP), Melville, N.Y. Palmetto Pharmaceuticals Inc. , Lexington, Mass. Pari GmbH , Starnberg, Germany Protemix Corp. Ltd....

...Cardiovascular and metabolic company Protemix (Auckland, New Zealand ) raised US$14.5 million in the first closing...
...copper chelating agent has Fast Track designation in the U.S. Novartis Venture's Reinhard Ambros joined Protemix's...

...Christopher Krueger as SVP and CBO, formerly SVP of business development and strategic alliances at Protemix Corp. Ltd....

...diabetes. Laszarin is an orally-active small molecule that selectively chelates the oxidized form of copper. Protemix...

...Cardiovascular and metabolic company Protemix (Auckland, New Zealand ) hired Larry Ellingson as CEO. Ellingson, who...
...will remain a director of the association after June, when his term as chairman ends. Protemix's...